Semaglutide is a modified molecule our bodies make, called a GLP-1 analog. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.

• Delays how quickly our stomachs digest food, leading to a feeling of fullness and satisfaction with smaller meal sizes.

• Slows intestinal motility so you will feel fuller longer after meals.

• Lowers blood sugars, in part by reducing the production of sugar in the liver.

• Stimulates insulin secretion by the pancreas.

• Decreases inflammation throughout the body, which leads to Adiponectin release and fat lipolysis.

Tirzepatide is a once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.

• Delays how quickly the stomach digests food, leading to a feeling of fullness and satisfaction with smaller meal sizes.

• Slows intestinal motility so you will feel fuller longer after meals.

• Dual action receptors allow for lower blood sugars, in part by reducing the production of sugar in the liver.

• Stimulates insulin secretion by the pancreas.

• GIP increases energy expenditure, resulting in weight loss.